Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.

Octapharma is a global healthcare company and one of the largest human protein manufacturers in the world, specializing in the development and production of human proteins from human plasma and human cell lines. Headquartered in Switzerland, the company operates six manufacturing facilities and over 190 plasma donation centers across Europe and the United States. Its therapeutic focus spans hematology, immunotherapy, and critical care, providing life-saving treatments for patients with rare and chronic conditions. As a family-owned entity, Octapharma reinvests heavily in research and development to advance its portfolio of recombinant and plasma-derived therapies. The company's products, such as Nuwiq and Octagam, are available in over 118 countries worldwide.